Capecitabine (Xeloda) News, Updated Regularly

Randomized Phase 2 Study Of IMC-A12 For Her2-Expressing Advanced ... - Phramalive.com
November 19, 2008, 5:09 am

NEW YORK, Nov 19, 2008 (BUSINESS WIRE) -- ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed randomized Phase 2 clinical ...

Lapatinib blocks the growth of breast cancer cells that spread to the ... - Xagena Medical News
November 12, 2008, 11:25 pm

Using laboratory and mouse models of human breast cancer, researchers have found that a small molecule capable of targeting specific proteins on the surface of breast cancer cells can inhibit the growth of breast cancer cells that migrate to the ...

Take a Chill, Pill Why oral cancer drugs are not all they're cracked ... - Slate
October 20, 2008, 5:57 pm

Pills In the past few years, the world?or at least the portion of it dealing with cancer and its treatment?has gone gaga for oral drugs. Ever since the stunning success of Gleevec , a once-daily anti-leukemia capsule, patients, doctors, and drug ...

Biotech Mailbag: Study Boosts ImmunoGen - Street.Com
October 16, 2008, 5:55 pm

Let's get right to your email. Vic R. asks for an ImmunoGen ( IMGN Quote - Cramer on IMGN - Stock Picks ) update after Tuesday's third-quarter earnings report from Genentech ( DNA Quote - Cramer on DNA - Stock Picks ) . Genentech's pipeline update ...

UK's NICE turns down Glaxo Tyverb offer - Reuters
October 14, 2008, 10:26 am

LONDON (Reuters) - Britain's healthcare cost effectiveness watchdog NICE has rebuffed GlaxoSmithKline's latest bid to get its drug Tyverb - for women with advanced breast cancer - into the state health system, the company said on Tuesday. Glaxo said ...

Breast cancer sufferer given hope by new drug - Daily Telegraph
October 26, 2008, 8:42 pm

The mother-of-three from Great Dunmow in Essex was diagnosed with breast cancer in January 2006 after discovering a lump on her right arm whilst having a shower. She underwent a mastectomy, and had chemotherapy and radiotherapy, but her cancer was ...

Maintaining Quality of Life in Patients With Refractory Metastatic ... - Medscape News
October 20, 2008, 5:57 pm

Despite the many cytotoxic agents, such as the taxanes and anthracyclines, that are available to treat metastatic breast cancer, resistance to these agents will develop in some women that will require other therapies. Ideally, such therapies will ...

Pancreatic Cancer, the Silent Disease - MedicineNet.com
October 10, 2008, 10:16 am

I was diagnosed with pancreatic cancer on May 25 of this year. On a routine yearly blood test, I was found to have slightly elevated blood levels of liver enzymes (my alkaline phosphatase , ALT , and AST were mildly elevated). Since I had no symptoms ...

Genentech Q3 2008 Earnings Call Transcript - Seekingalpha.com
October 13, 2008, 5:58 pm

Good afternoon, ladies and gentlemen. My name is Gerald and I will be your conference operator. At this time, I would like to welcome everyone to the Genentech third quarter 2008 earnings conference call. (Operator Instructions) It is now my pleasure ...

Roche posts sustained double-digit sales growth for the first nine ... - WebWire
October 20, 2008, 5:57 pm

* Group sales up 10% in local currencies to 33.2 billion Swiss francs, excluding Tamiflu pandemic sales * Including Tamiflu pandemic sales, Group sales total 33.3 billion francs, an increase of 6% in local currencies and 13% in US dollars, and a ...

Are you looking for additional Xeloda (Capecitabine) news? Try our new "Capecitabine News Focus" area.

Are you looking for additional Xeloda (Capecitabine) information? Try our new "Capecitabine Related Blog Entries" area.

Off-site Capecitabine (Xeloda) Links, User Submitted

The following links have been collected through user bookmark submission in the Capecitabine_Xeloda category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Tue Feb 5

• A Phase III Trials Program Exploring the Integration of Bevacizumab, Everolimus (RAD001), and Lapatinib Into Current Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer - Full Text View - ClinicalTrials .gov: A breast cancer trials. Setting III is for erbb2 postive patients w/o brain metastaces. Combination of druges includes epirubicin / cyclophosphami de followed by docetaxel / capecitabine with either trastuzumab or lapatinib (ECH-TXH vs. ECL-TXL) To c
• A Brain Metastases In ErbB2-Positive Breast Cancer - Tabular View - ClinicalTrials .gov: Breast cancer to brain. PI is GlaxoSmithKlin e. 2 arms: lapatinib is when given in combination with either capecitabine or topotecan to treat patients with ErbB2 overexpressing breast cancer

Wed Jan 2

• NEJM -- Capecitabine and Oxaliplatin for Advanced Esophagogastri c Cancer

Mon Nov 26

• Xeloda (kapesitabiini ) 150 mg kalvopäällyste iset tabletit - Lääkeinfo.fi - Valmisteen mukaan: Xeloda 150 mg kalvopäällyste iset tabletit kapesitabiini
• OralChemo.org - oral cyclophosphami de: Oral cyclophosphami de has been used since the early 1970s in combination with methotrexate and fluorouracil/5 -FU for the treatment of breast cancer that has spread. It is also used in this combination as adjuvant therapy following surgery, where it improv
• Capecitabine - Wikipedia, the free encyclopedia: Capecitabine (INN) (IPA: [ke?p?sa?t?bin ]) is an orally-adminis tered chemotherapeut ic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, wh

Off-site Capecitabine Research Links

If you still need additional information on Capecitabine then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.